Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1991-4-25
pubmed:abstractText
The only peptide of Sendai virus that is recognized by cytotoxic T lymphocytes (CTL) in B6 mice was found with (i) the use of recombinant vaccinia virus constructs containing separate genes of Sendai virus and (ii) a set of overlapping peptides completely spanning the identified nucleoprotein (NP) gene product. This immunodominant NP peptide is recognized by Sendai virus-specific CTL that are known to have therapeutic effects in vivo. By subcutaneous immunization, this peptide induced Sendai virus and NP peptide-specific CTL memory responses in vivo. Most importantly, mice that had been immunized with this peptide were protected against a lethal virus dose, indicating that viral peptides can be used as antiviral T-cell vaccines. The induction of T-cell memory by free peptide immunization potentially has wide applicability in biology and medicine, including protection against infectious disease.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-1130679, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-1692084, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2168920, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2199065, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2420472, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2443447, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2465904, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2536110, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2542021, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2555063, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2578661, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-2586628, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-3018121, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-3052209, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-6092688, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-6185570, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-6204335, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-6206190, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-6267157, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-6311565, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-6316257, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-6332201, http://linkedlifedata.com/resource/pubmed/commentcorrection/1848698-6601180
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2283-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.
pubmed:affiliation
Division of Immunology, The Netherlands Cancer Institute, Amsterdam.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't